Srini Tenjarla - 03 Feb 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role: SVP, CMC & Formulation
Signature: /s/ Srini Tenjarla
Issuer symbol: SER
Transactions as of: 03 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2026, 08:29:18 UTC
Previous filing: 17 Jul 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tenjarla Srini	SVP, CMC & Formulation	601 GENOME WAY, SUITE 2001, HUNTSVILLE	/s/ Srini Tenjarla	17 Feb 2026	0002029985

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SER	Stock Option (right to buy)	Award	$0	+69,000		$0.000000	69,000	03 Feb 2026	Common Stock	69,000	$2.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.